Company intelligence / Profile preview

Biotrial

Ownership: Private
Employees: ~265
Development stage: Other

Overview

Biotrial is an independent mid-size full-service Contract Research Organization founded in France in 1989. It specializes in preclinical pharmacology and early-phase clinical development for pharmaceutical and biotechnology companies worldwide. The company operates state-of-the-art facilities in France and the United States, focusing primarily on Phase I studies with healthy volunteers or special populations but also supporting patient trials and device testing. With over three decades of experience, Biotrial offers expertise spanning preclinical to late-phase biometrics/bioanalysis/core lab support.

Modalities: Small moleculeBiologicDeviceProteinVaccinePeptides
Industry: Contract Research Organization

Partnerships

Not specifically disclosed; serves global pharma/biotech sponsors including large pharma companies and innovative startups

Beyond the preview

Go deeper on Biotrial.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biotrial.

Explore the full profile